COVID-19 Associated Coagulopathy in Egypt

Assiut University

Status: Completed

Conditions: Coagulopathy

Study type: Observational

Funder types: Other

Identifiers

NCT04507230

17300413

Details and patient eligibility

About

Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation (DIC) compared to 0.6% of survivors.

Full description

studying the detailed coagulation screen and second line coagulation parameters including both thrombophilia screen and other acute phase coagulation factors.

Enrollment: 106 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with COVID 19 positive by RT- PCR

Exclusion criteria

• no exclusions